Uranium mining giant Cameco (TSX: CCO) has been a standout performer in the nuclear industry, rewarding investors with a staggering 625% rally over the past five years. But with the stock trading near recently set all-time highs, long-term-oriented investors are right to ask: Can the nuclear powerhouse’s momentum continue? Let’s explore where Cameco stock could be by 2030.
Source: Getty Images
Revenue Growth: Still more room for Cameco’s sales to run?
Cameco’s revenue surged 35% year-over-year during the first half of 2025 (H1 2025), reaching $1.7 billion. With annual deliveries of 28 million pounds of uranium locked in through 2029, and stronger commitments in the near term, the company has clear visibility into future revenue.
However, revenue growth rates will, most likely, moderate from the explosive pace of recent years. Projections suggest mid-to-high single-digit annual revenue growth through 2030, driven by higher realized uranium prices and incremental volume increases.
If uranium demand continues to climb globally, supported by growing nuclear energy commitments from 31 countries, Cameco’s top line could exceed current market expectations.
Margin expansion and restarting mines
As previously mothballed assets like McArthur River and Cigar Lake ramp up production, economies of scale should improve operating margins over the next five years. Management has highlighted cost containment as a priority, and with uranium prices likely to remain elevated, operating margins could stabilize around 15% or higher. A potential restart of U.S. operations, along with advances in Australian and Canadian projects moving into production, further supports efficiency gains.
Cameco has development projects, including Millennium, Yeelirrie, and Kintyre. One or two may have graduated into production by 2030, increasing Cameco’s uranium supply and contracting capacity.
Acquisition appetite and diversification
Cameco isn’t just a uranium miner. It has established interests deep into the nuclear energy value chain. Its 49% stake in Westinghouse, a global nuclear services leader, which was acquired in 2023, added diversification and high-margin revenue. Westinghouse’s recent wins concerning profit shares in projects by South Korean competitors and interests in the Dukovany project in the Czech Republic contribute significantly to its earnings before interest, taxes, depreciation, and amortization (EBITDA), which Cameco expects to grow at 6–10% annually over the next five years.
Cameco historically had a good appetite for acquisitions during uranium’s good times, and the next five years could see a handful of transactions. New acquisitions may potentially add new revenue streams in enrichment, conversion, or even next-generation nuclear technology.
By 2030, Global Laser Enrichment (GLE), jointly owned by Cameco and Silex Systems, could be entering the production stage, further transforming the business within the next five years.
Geopolitical risks and opportunities
Trade tensions and protectionism pose risks, but also opportunities. As Europe and the U.S. diversify away from Russian nuclear fuel, Cameco’s Canadian and U.S. assets become increasingly strategic. However, potential tariffs or trade barriers under a Trump administration could create headwinds if natural uranium and nuclear products get removed from the current tariff-exempt schedule. The company’s geographically diversified operations mitigate some of this risk.
Valuation: The elephant in the room
Cameco stock trades at a lofty price-earnings (P/E) multiple of 84, far above global uranium supply leader Kazatomprom’s 10. This premium reflects Cameco’s exposure to North American stock markets, its integrated business model, and high growth expectations. But if revenue growth slows to single digits, the multiple could compress.
Bay Street analysts project earnings per share (EPS) growth of 10.8% annually over the next five years. If EPS reaches $2 by 2030 and the P/E multiple halves to 40, the stock could trade around $80, far below today’s $105.
For Cameco stock to appreciate, Cameco must outperform EPS growth expectations or maintain a rich valuation.
The Foolish bottom line
Cameco’s revenue and earnings future is bright, but it’s not without challenges. The company has secured contracts, diversified into services, and positioned itself as a low-risk uranium supplier in a world economy that’s re-embracing nuclear energy. However, its stock valuation already prices in near-perfect execution.
For investors buying today, the key question is whether Cameco can grow EPS fast enough to justify its premium. If uranium prices surge or acquisitions accelerate growth, the stock could defy skeptics. But if growth slows or multiples contract, investment gains may be limited during the next five years.
Perhaps buying on pullbacks could be a rewarding strategy for new money. Personally, I keep holding my Cameco stock position.
